Lumida
/CPRT
⌘K
Copart Inc

Copart Inc

CPRT
$29.95USD-2.60%-0.80 today

MARKET CAP

27.7B

P/E (TTM)

19.8x

FWD P/E

18.6x

DAY RANGE

$30 – $32

52W RANGE

$27
$49

AI Summary

Stalk
Sell NowMedium

CPRT is entrenched in a Stage 4 Decline after decisively breaking below its 50-day SMA and key horizontal support on heavy volume, confirming a bearish medium-term bias. Short-term conditions remain unfavorable with price extending below declining 9/20 EMAs and oversold RSI failing to show bullish divergence. Execution posture is Sell Now to participate in continued downside, while monitoring for a potential relief bounce into broken EMAs.

  • Q3 revenue +2.1% to $1.24 B; gross profit +3.7% to $572.6 M
  • US insurance ASPs up 4.6% YoY; total loss frequency at 23.6%
  • US insurance unit volume down 4.2% YoY, weakening auction supply
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$2.7B$3.5B$3.9B$4.2B$4.6B
YoY %+22.1%+30.0%+10.5%+9.5%+9.7%
P / Sales13.0x8.9x11.0x12.0x9.5x
EV / Sales13.0x8.7x11.0x11.9x9.1x
Gross Profit, Adj.$2.3B$2.9B$1.7B$1.9B$2.1B
YoY %+18.5%+24.3%-40.4%+9.8%+10.1%
Margin %87.1%83.3%44.9%45.0%45.2%
EV / Gross Profit14.9x10.4x24.5x26.4x20.2x
EBITDA, Adj.$1.3B$1.5B$1.6B$1.8B$1.9B
YoY %+36.9%+20.2%+8.8%+7.0%+8.6%
Margin %46.8%43.2%42.5%41.6%41.2%
EV / EBITDA27.8x20.1x25.8x28.6x22.2x
EBIT$1.1B$1.4B$1.5B$1.6B$1.7B
YoY %+39.3%+21.0%+8.1%+5.7%+7.9%
Margin %42.2%39.3%38.4%37.1%36.5%
EV / EBIT30.9x22.1x28.6x32.0x25.0x
Net Income$936.5M$1.1B$1.2B$1.4B$1.6B
YoY %+33.8%+16.4%+13.5%+10.1%+13.9%
Net Margin34.8%31.1%32.0%32.2%33.4%
EPS (GAAP)$0.97$1.13$1.28$1.40$1.59
YoY %+32.9%+16.5%+13.3%+9.4%+13.6%